AAOMS Annual Meeting

The FDA has approved a new option for the treatment of patients with locally advanced or metastatic urothelial carcinoma.

The FDA has approved a new option for the treatment of patients with locally advanced or metastatic urothelial carcinoma.

The US Food and Drug Administration has expanded the approval of a drug used to treat cystic fibrosis.

As an update to the safety alert issued last year, the FDA warns of a possible link to foot and leg amputation.

As an update to the safety alert issued last year, the FDA warns of a possible link to foot and leg amputation.

As an update to the safety alert issued last year, the FDA warns of a possible link to foot and leg amputation.

The FDA has posted a correction for this press release: "The notice posted to the Hematology/Oncology Approvals web page yesterday afternoon regarding an approval for the treatment of Hodgkin lymphoma...

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.